Loading...
XIST
SELEC
Market cap1.08bUSD
Nov 12, Last price  
74.00TRY
Name

Selcuk Ecza Deposu Ticaret ve Sanayi AS

Chart & Performance

D1W1MN
XIST:SELEC chart
P/E
22.32
P/S
0.36
EPS
3.32
Div Yield, %
0.34%
Shrs. gr., 5y
Rev. gr., 5y
48.50%
Revenues
128.62b
+31.62%
3,150,807,0403,708,483,9604,046,511,4805,028,769,5884,902,235,8955,074,497,9224,902,072,8235,238,018,2126,386,429,8997,480,344,5508,643,408,12210,686,329,97913,467,345,52617,808,667,10121,027,099,07526,214,644,33044,712,209,72397,719,059,416128,619,630,000
Net income
2.06b
+822.31%
97,286,090161,576,610160,672,841231,720,434183,932,004138,563,037143,683,723152,325,251165,392,514190,697,176243,615,801301,098,488391,267,757694,895,542586,795,628922,713,0752,381,369,521223,213,4782,058,725,000
CFO
-8.77b
L
-22,588,519149,594,54475,897,520248,463,622122,942,92031,921,63655,143,76663,564,603113,993,440-10,089,626206,570,212154,583,44756,320,061851,776,748498,992,170186,872,959-356,465,7451,567,578,709-8,774,802,000
Dividend
Apr 18, 20240.25 TRY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a distribution channel between pharmaceutical manufacturers, hospitals, and pharmacies. It also operates a pharmaceutical warehouse. The company was founded in 1958 and is headquartered in Istanbul, Turkey. Selçuk Ecza Deposu Ticaret ve Sanayi A.S. is a subsidiary of Selçuk Ecza Holding A.S.
IPO date
Apr 26, 2006
Employees
Domiciled in
TR
Incorporated in
TR

Valuation

Title
TRY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT